Insider Transactions in Q2 2025 at Senseonics Holdings, Inc. (SENS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2025
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
79,646
-0.61%
|
$0
$0.51 P/Share
|
|
Jun 16
2025
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
35,784
-1.18%
|
$0
$0.51 P/Share
|
|
Jun 16
2025
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,761
-1.08%
|
$0
$0.51 P/Share
|
|
Jun 16
2025
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,853
-1.11%
|
$0
$0.51 P/Share
|
|
Jun 16
2025
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,263
-0.89%
|
$0
$0.51 P/Share
|
|
May 23
2025
|
Brian B Hansen |
BUY
Grant, award, or other acquisition
|
Direct |
842,084
+50.0%
|
-
|
|
May 23
2025
|
Timothy T Goodnow President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,025,956
+13.52%
|
-
|
|
May 23
2025
|
Frederick T. Sullivan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
693,481
+18.48%
|
-
|
|
May 23
2025
|
Mukul Jain Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
990,688
+15.35%
|
-
|
|
May 23
2025
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
111,386
+6.4%
|
-
|
|
May 23
2025
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
111,386
+7.81%
|
-
|
|
May 23
2025
|
Kenneth L Horton GC & Corp. Development Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
505,251
+14.23%
|
-
|
|
May 23
2025
|
Francine Kaufman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
455,716
+14.91%
|
-
|
|
May 23
2025
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
111,386
+5.22%
|
-
|
|
May 23
2025
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
111,386
+8.27%
|
-
|
|
May 23
2025
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct |
111,386
+14.82%
|
-
|
|
May 23
2025
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
111,386
+9.42%
|
-
|
|
May 15
2025
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
379,164
-3.35%
|
$0
$0.55 P/Share
|
|
May 15
2025
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
167,085
-6.17%
|
$0
$0.55 P/Share
|
|
May 15
2025
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
260,393
-5.5%
|
$0
$0.55 P/Share
|
|
May 15
2025
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
101,587
-4.52%
|
$0
$0.55 P/Share
|
|
May 15
2025
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
112,811
-4.55%
|
$0
$0.55 P/Share
|
|
Apr 01
2025
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
22,183
+1.44%
|
$0
$0.66 P/Share
|
|
Apr 01
2025
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
12,219
+1.26%
|
$0
$0.66 P/Share
|
|
Apr 01
2025
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
19,363
+1.69%
|
$0
$0.66 P/Share
|
|
Apr 01
2025
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
21,243
+1.73%
|
$0
$0.66 P/Share
|